Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TPI ASM8 in mild to moderate asthma
NCT00402948Phase 2Terminated
- Sponsor
- Syntara Limited
- Start
- Feb 2007
- Primary completion
- Nov 2007
- Modality
- Modified DNA Oligonucleotides, Single-strand DNA, Antisense Oligonucleotides (ASOs)
- Countries
- 1
01
Overview
A Phase 2 trial of ASM8 in asthma, sponsored by Syntara Limited. Started Feb 2007; status: terminated.
02
Drugs
ASM8
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00402948.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00402948.